Cargando…
Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical marker
Liver fibrosis is a precursor of liver cirrhosis, which is associated with increased mortality. Though liver biopsy remains the gold standard for the diagnosis of fibrosis, noninvasive biochemical methods are cost-effective, practical and are not linked with major risks of complications. In this res...
Autor principal: | Vela, Driton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016890/ https://www.ncbi.nlm.nih.gov/pubmed/30134796 http://dx.doi.org/10.1186/s10020-018-0008-7 |
Ejemplares similares
-
Hepcidin, an emerging and important player in brain iron homeostasis
por: Vela, Driton
Publicado: (2018) -
The Dual Role of Hepcidin in Brain Iron Load and Inflammation
por: Vela, Driton
Publicado: (2018) -
Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications
por: Vela, Driton, et al.
Publicado: (2018) -
Factor analysis of the biochemical markers related to liver cirrhosis
por: Kim, Hyun-Jin, et al.
Publicado: (2015) -
Insulin treatment corrects hepcidin but not YKL-40 levels in persons with type 2 diabetes mellitus matched by body mass index, waist-to-height ratio, C-reactive protein and Creatinine
por: Vela, Driton, et al.
Publicado: (2017)